| 货号 | 包装规格 | 操作 |
|---|---|---|
| SML3265-1MG | 1 mg |
≥95%（HPLC）
DAPTA is a potent CCR5 antagonist, an amidated octapeptide corresponding to an HIV envelope glycoprotein gp120 (gp160)-derived sequence (aa 185-192; the SF-2 isolate) that competes against gp120-CD4 complex for interaction with CCR5 (IC50 = 0.42 nM against gp120CM235 binding to CCR5/CD4 cells, IC50 = 1.5/1.8 nM against gp120BaL/sCD4 or gp120CM235/sCD4 binding to CCR5+/CD4- cells). DAPTA blocks CCR5-dependent HIV host cell entry in cultures and in vivo.
有效的CCR 5拮抗剂，在培养物和体内阻断CCR 5依赖性HIV宿主细胞进入。
| 英文名称 | DAPTA trifluoroacetate |
| NACRES | NA.77 |
| UNSPSC | 51111800 |
| 含量测定 | ≥95%（HPLC） |
| 形态 | 粉末 |
| 颜色 | 白色至类白色 |
| 储存温度 | −20°C |
| 质量等级 | 100 |
| 包装规格（货号 SML3265-1MG） | 1 mg |
